Admetsys Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 5


  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 14

Admetsys General Information


Developer of a clinical robotic system designed for blood analysis and metabolic control. The company's real-time diagnostic platform uses a standard IV line, which draws a small blood sample every few minutes to measure glucose electrochemically and returns the blood back to the patient along with a closed-loop artificial pancreas in hospital and surgical care and remote monitoring applications, enabling hospitals to effectively control blood glucose levels and alleviate stresses associated with diabetic care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 21 Drydock Avenue
  • 6th Floor
  • Boston, MA 02210
  • United States
+1 (800) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Admetsys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Early Stage VC 06-Jun-2017 $1.5M 00.000 Completed Generating Revenue
10. Early Stage VC 27-Apr-2017 00000 00.000 Completed Generating Revenue
9. Accelerator/Incubator 28-Jun-2016 00.000 Completed Generating Revenue
8. Accelerator/Incubator 08-Mar-2016 000 00.000 Completed Generating Revenue
7. Accelerator/Incubator 29-Jul-2015 000.00 Completed Startup
6. Accelerator/Incubator 14-Jul-2015 000.00 Completed Startup
5. Accelerator/Incubator 24-Jun-2015 000.00 Completed Startup
4. Grant 15-Apr-2015 00.00 000.00 Completed Startup
3. Accelerator/Incubator 09-Mar-2015 $37.4K Completed Startup
2. Accelerator/Incubator 01-Dec-2014 $37.4K $37.4K Completed Startup
To view Admetsys’s complete valuation and funding history, request access »

Admetsys Comparisons

HQ Location
Total Raised
Post Valuation
Developer of a clinical robotic system designed for blood analysis and metabolic control. The company's real-time diagno
Monitoring Equipment
Boston, MA
5 As of 2023
0000000000 0 00.000


strud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000000000 000000000
San Diego, CA
00 As of 0000
000 0000-00-00
00000000000 000.00


m ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
0000000000 000000000
Basel, Switzerland
0000 As of 0000
0.000 0000-00-00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Admetsys Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlySens Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
00000000 00000000 Formerly PE-Backed Basel, Switzerland 0000 000000000000
000000 Formerly VC-backed San Diego, CA 0000 00000 000000000 00000
0000000000 Corporation Rutherford, NJ 0 000.00 000000000 000.00
00000000 Private Equity-Backed Malvern, PA 0000 000.00 0000000 0000 000.00
You’re viewing 5 of 12 competitors. Get the full list »

Admetsys Patents

Admetsys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210038877-A1 Intravascular port based sensing and treatment system Pending 12-Mar-2018 00000000000
US-11357425-B2 Intraosseous implanted biological sensor Active 12-Mar-2018 0000000000 0
US-20210038130-A1 Intraosseous implanted biological sensor Active 12-Mar-2018 0000000000
US-20230131362-A1 Intraosseous implanted biological sensor Pending 12-Mar-2018 0000000000
US-20230282342-A1 System and method for clinical quality and safety automation Pending 12-Mar-2018 G16H40/20
To view Admetsys’s complete patent history, request access »

Admetsys Executive Team (3)

Name Title Board Seat Contact Info
Jeffrey Valk Co-Founder, Chief Executive Officer, and President
Glenn Robertelli Co-Founder & Chief Operating Officer
Timothy Valk MD Co-Founder & Chief Scientist
To view Admetsys’s complete executive team members history, request access »

Admetsys Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Admetsys Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Baptist Health System Corporation 000 0000 000000 0
BlueCross and BlueShield Association Corporation 000 0000 000000 0
T1D Exchange Corporation 000 0000 000000 0
Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies University Minority 000 0000 000000 0
TiE-Boston Angel Group 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »